Tilray Brands (TLRY) EBITDA (2017 - 2026)
Tilray Brands (TLRY) posted EBITDA of -$26.4 million for Q1 2026, down 18.43% on a QoQ basis from -$22.3 million in Q4 2025, and up 96.53% year-over-year from -$13.4 million in Q1 2025.
Tilray Brands (TLRY) EBITDA (2017 - 2026) Analysis & Trends
Tilray Brands' EBITDA history runs 10 years deep, the most recent figure standing at -$26.4 million for Q1 2026.
- Quarterly EBITDA rose 96.53% year-over-year to -$26.4 million in Q1 2026, while the trailing twelve-month figure through Feb 2026 was -$1.5 billion (down 74.28% YoY) and the FY2025 annual result came in at -$2.3 billion, down 1206.31% from the prior year.
- EBITDA was -$26.4 million for Q1 2026 at Tilray Brands, down from -$22.3 million in the prior quarter.
- Across five years, EBITDA topped out at $2.1 million in Q3 2025 and bottomed at -$1.4 billion in Q2 2025.
- A 5-year average of -$256.4 million and a median of -$41.8 million in 2023 frame the typical range for EBITDA.
- Peak annual rise in EBITDA reached 105.72% in 2025, while the deepest fall reached 8637.66% in 2025.
- Tilray Brands' EBITDA stood at -$51.8 million in 2022, then rose by 19.37% to -$41.8 million in 2023, then dropped by 1.1% to -$42.2 million in 2024, then surged by 47.23% to -$22.3 million in 2025, then fell by 18.43% to -$26.4 million in 2026.
- Business Quant data shows TLRY's EBITDA at -$26.4 million in Q1 2026, -$22.3 million in Q4 2025, and $2.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 652.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 833.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -2.65 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 325.80 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -79.70 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 193.40 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 291.00 Mn |
| 10 | Tilray Brands | 465.02 Mn | 373.06 Mn | 54.95 Mn | -26.39 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | -26.39 Mn |
| Nov 30, 2025 | -22.28 Mn |
| Aug 31, 2025 | 2.09 Mn |
| May 31, 2025 | -1.44 Bn |
| Feb 28, 2025 | -759.93 Mn |
| Nov 30, 2024 | -42.22 Mn |
| Aug 31, 2024 | -36.57 Mn |
| May 31, 2024 | -16.53 Mn |
| Feb 29, 2024 | -82.10 Mn |
| Nov 30, 2023 | -41.76 Mn |
| Aug 31, 2023 | -34.36 Mn |
| May 31, 2023 | -89.98 Mn |
| Feb 28, 2023 | -1.21 Bn |
| Nov 30, 2022 | -51.79 Mn |
| Aug 31, 2022 | -21.18 Mn |
| May 31, 2022 | -467.42 Mn |
| Feb 28, 2022 | -18.08 Mn |
| Nov 30, 2021 | -55.53 Mn |
| Aug 31, 2021 | -69.37 Mn |
| May 31, 2021 | -73.69 Mn |